Kidney Cancer News

Casdatifan Exhibits 1+ Year Survival in Later-Line Kidney Cancer - CancerNetwork

Casdatifan Exhibits 1+ Year Survival in Later-Line Kidney Cancer CancerNetwork

Five-Year Cryoablation Data Show Durable Kidney Cancer Control - CUREtoday.com

Five-Year Cryoablation Data Show Durable Kidney Cancer Control CUREtoday.com

Muharrem Coşkunpınar: Expanding Perspectives in Metastatic Bladder and Kidney Cancer Care - Oncodaily

Muharrem Coşkunpınar: Expanding Perspectives in Metastatic Bladder and Kidney Cancer Care Oncodaily

IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 - PR Newswire

IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 PR Newswire

After cancer diagnoses, Tewksbury family seeks answers about landfill contaminated with PFAS - WCVB

After cancer diagnoses, Tewksbury family seeks answers about landfill contaminated with PFAS WCVB

ASCO GU 2026 Preview: Highlights of Key Trials in Bladder, Kidney, Prostate, and Rare Cancers - Targeted Oncology

ASCO GU 2026 Preview: Highlights of Key Trials in Bladder, Kidney, Prostate, and Rare Cancers Targeted Oncology

IceCure Medical completes 5-year follow up study in kidney cancer cryoablation - Yahoo

IceCure Medical completes 5-year follow up study in kidney cancer cryoablation Yahoo

Warning Signs of Kidney Cancer You Shouldn’t Ignore - Fox Chase Cancer Center

Warning Signs of Kidney Cancer You Shouldn’t Ignore Fox Chase Cancer Center

Kidney cancer specialists: 3 things to know about renal cell carcinoma (RCC) - MD Anderson Cancer Center

Kidney cancer specialists: 3 things to know about renal cell carcinoma (RCC) MD Anderson Cancer Center

Experts Preview Practice-Changing Data Ahead of 2026 ASCO GU - CUREtoday.com

Experts Preview Practice-Changing Data Ahead of 2026 ASCO GU CUREtoday.com

Arcus reports casdatifan trial data in kidney cancer patients - Investing.com

Arcus reports casdatifan trial data in kidney cancer patients Investing.com

A clinically validated AI framework for kidney cancer detection and characterization | Communications Medicine - Nature

A clinically validated AI framework for kidney cancer detection and characterization | Communications Medicine Nature

María Teresa Bourlon, MD, MS, FASCO, previews practice-changing research at ASCO GU 2026 - Urology Times

María Teresa Bourlon, MD, MS, FASCO, previews practice-changing research at ASCO GU 2026 Urology Times

Kidney Cancer Symptoms: Early Warning Signs and What to Look For | U.S. News - Health US News

Kidney Cancer Symptoms: Early Warning Signs and What to Look For | U.S. News Health US News

Kidney Cancer Experts Preview Practice-Shaping Trials Taking Center Stage at ASCO GU 2026 - OncLive

Kidney Cancer Experts Preview Practice-Shaping Trials Taking Center Stage at ASCO GU 2026 OncLive

Arcus presents kidney cancer drug data showing extended survival - StreetInsider

Arcus presents kidney cancer drug data showing extended survival StreetInsider

Kidney Cancer Cases Are Projected to Double by 2050, Says Study - Fox Chase Cancer Center

Kidney Cancer Cases Are Projected to Double by 2050, Says Study Fox Chase Cancer Center

Targeting of HIF2-driven cachexia in kidney cancer - Nature

Targeting of HIF2-driven cachexia in kidney cancer Nature

Late-line kidney cancer patients top a year without progression on Arcus drug - Stock Titan

Late-line kidney cancer patients top a year without progression on Arcus drug Stock Titan

ICCM Completes Key 5-Year Follow-Up in Kidney Cancer Clinical Tr - GuruFocus

ICCM Completes Key 5-Year Follow-Up in Kidney Cancer Clinical Tr GuruFocus

A Cancer Surgery and the Pain I Didn’t Want to Face - The New York Times

A Cancer Surgery and the Pain I Didn’t Want to Face The New York Times

Combing data, researchers confirm elevated kidney cancer rates in Merrimack and Manchester - New Hampshire Bulletin

Combing data, researchers confirm elevated kidney cancer rates in Merrimack and Manchester New Hampshire Bulletin

Kidney cancer rates are higher in Merrimack. Scientists say more research is warranted. - New Hampshire Public Radio

Kidney cancer rates are higher in Merrimack. Scientists say more research is warranted. New Hampshire Public Radio

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer - UCLA Health

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer UCLA Health

Physical Activity After Diagnosis Linked to Lower Cancer Mortality - EMJ | Elevating the quality of healthcare globally

Physical Activity After Diagnosis Linked to Lower Cancer Mortality EMJ | Elevating the quality of healthcare globally

Clinical Cancer Trial for Kidney Cancer SABR Immunotherapy - Froedtert & MCW

Clinical Cancer Trial for Kidney Cancer SABR Immunotherapy Froedtert & MCW

Mom's Debilitating Symptoms Dismissed By 8 Doctors Before Kidney Cancer Diagnosis: 'Nobody Took Me Seriously' - People.com

Mom's Debilitating Symptoms Dismissed By 8 Doctors Before Kidney Cancer Diagnosis: 'Nobody Took Me Seriously' People.com

Epigenetically-controlled CEBPB regulates kidney cancer tumorigenesis via GPD1L-mediated ether lipid synthesis - Nature

Epigenetically-controlled CEBPB regulates kidney cancer tumorigenesis via GPD1L-mediated ether lipid synthesis Nature

'It was even more rare' | How an Arkansas man beat kidney cancer - thv11.com

'It was even more rare' | How an Arkansas man beat kidney cancer thv11.com

Kidney cancer caregiver: The Institute for Data Science in Oncology (IDSO) can help unlock advances to end cancer - MD Anderson Cancer Center

Kidney cancer caregiver: The Institute for Data Science in Oncology (IDSO) can help unlock advances to end cancer MD Anderson Cancer Center